戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 translation is carried out in the absence of elongation factor P.
2 cus encodes a protein similar in sequence to elongation factor P, a protein thought to be involved in
3                                              Elongation factor P (EF-P) accelerates diprolyl synthesi
4                  The prokaryotic translation elongation factor P (EF-P) and the eukaryotic/archaeal c
5                                              Elongation factor P (EF-P) binds to ribosomes requiring
6                                  Translation elongation factor P (EF-P) in Bacillus subtilis is requi
7                                              Elongation factor P (EF-P) is a conserved ribosome-bindi
8                                              Elongation factor P (EF-P) is a universally conserved ba
9                                              Elongation factor P (EF-P) is an essential protein that
10                                    Bacterial elongation factor P (EF-P) is the ortholog of archaeal a
11                                              Elongation factor P (EF-P) prevents ribosome stalling at
12 Post-translational modification of bacterial elongation factor P (EF-P) with (R)-beta-lysine at a con
13                          In a recent report, elongation factor P (EF-P), putatively essential for ena
14                     Strikingly, we show that elongation factor P (EF-P), traditionally known to allev
15 d ribosomes are rescued by the translational elongation factor P (EF-P), which by stimulating peptide
16 nship, we examined the bacterial translation elongation factor P (EF-P), which plays a critical role
17 ling at poly-Pro motifs is alleviated by the elongation factor P (EF-P).
18 ia, stalling at PPP motifs is rescued by the elongation factor P (EF-P).
19 intenance and to have a strong dependence on elongation factor P (EFP).
20 y than the wild-type strain, indicating that elongation factor P is important but not essential for t
21 he requirements for positive transcriptional elongation factor (P-TEF) b activity.
22 the importance of the positive transcription elongation factor (P-TEF)b in control of global RNA synt
23 ated AhR recruits the positive transcription elongation factor (P-TEFb) and RNA polymerase II (RNA PI
24 artner of CDK9 in the positive transcription elongation factor (P-TEFb) complex, and binds cooperativ
25 linT1) subunit of the positive transcription elongation factor (P-TEFb) complex, which then cooperati
26 yclin T1 (CDK9/CCNT1) positive transcription elongation factor (P-TEFb) complex.
27 evealed roles for the positive transcription elongation factor (P-TEFb) component Cyclin T1 (Ccnt1).
28                   The positive transcription elongation factor (P-TEFb) is required for the transcrip
29 evating levels of the positive transcription elongation factor (P-TEFb), instating a large proliferat
30 tors, including the positive transcriptional elongation factor (P-TEFb), the bromodomain-containing p
31                       Positive transcription elongation factor (P-TEFb), which is composed of CDK9 an
32  only recruited after positive transcription elongation factor (P-TEFb)-mediated phosphorylation and
33                   The metazoan transcription elongation factor P-TEFb (CDK-9/cyclin T) is essential f
34        The RNA polymerase II transcriptional elongation factor P-TEFb (cyclin-dependent kinase 9/cycl
35  of the Tat-associated kinase TAK and of the elongation factor P-TEFb (positive transcription elongat
36 layed by the biogenesis of the transcription elongation factor P-TEFb (Positive Transcription Elongat
37 nd MePCE captures the positive transcription elongation factor P-TEFb and prevents phosphorylation of
38                          The transcriptional elongation factor P-TEFb directly bound pre-mRNA, and it
39      In contrast, the positive transcription elongation factor P-TEFb is a local explorer that oversa
40             The human positive transcription elongation factor P-TEFb is composed of two subunits, cy
41  BRCA1 but also associates with the positive elongation factor P-TEFb through interaction with the re
42 se CDK9, is a component of the transcription elongation factor P-TEFb which binds the human immunodef
43 H and Tat-associated kinase (a transcription elongation factor P-TEFb) and requires the carboxyl-term
44 elongation by inactivating the transcription elongation factor P-TEFb, a CDK9-cyclin T1 (CycT1) heter
45 orks by activating the human transcriptional elongation factor P-TEFb, a CDK9-cyclin T1 heterodimer t
46 h components of the positive transcriptional elongation factor P-TEFb, a complex containing cyclin T1
47 e mediated through the binding of TAT-SF1 to elongation factor P-TEFb, a proposed component of the tr
48 sed to respond to the positive transcription elongation factor P-TEFb, and then enter productive elon
49             The human positive transcription elongation factor P-TEFb, consisting of a CDK9/cyclin T1
50 on by recruitment of the human transcription elongation factor P-TEFb, consisting of CDK9 and cyclin
51 on by recruitment of the human transcription elongation factor P-TEFb, consisting of Cdk9 and cyclin
52              Recently, a human transcription elongation factor P-TEFb, consisting of CDK9 kinase, cyc
53 1 (hCycT1), a major subunit of the essential elongation factor P-TEFb, has been proposed to act as a
54 h AFF4, ELLs, and the positive transcription elongation factor P-TEFb, providing evidence that the dy
55  polymerase II or cyclin T, a subunit of the elongation factor P-TEFb, reveals that all three factors
56  block is associated with recruitment of the elongation factor P-TEFb, the co-activator GRIP1, the ch
57 scription is mediated by human transcription elongation factor P-TEFb, which interacts with Tat and p
58  interaction with the positive transcription elongation factor P-TEFb.
59 ion is independent of positive transcription elongation factor P-TEFb.
60 or elongation mediated by the recruitment of elongation factor P-TEFb.
61 ion until it is counteracted by the positive elongation factor P-TEFb.
62 CDK9 and as a component of the transcription elongation factor P-TEFb.
63 re also components of positive transcription elongation factor P-TEFb.
64 er, and blockage of the assembly of the host elongation factor P-TEFb.
65  interaction with the positive transcription elongation factor, P-TEFb, and directs the factor to pro
66                   The positive transcription elongation factor, P-TEFb, controls the fraction of init
67 ieves a block to elongation by recruiting an elongation factor, P-TEFb, to the viral promoter.
68 es Tat to recruit the positive transcription elongation factor, P-TEFb, which functions to promote th
69  SCL transcription complex, and the positive elongation factors p-TEFb and FACT.
70 mponents that link this complex to two major elongation factors, P-TEFb and the PAF complex.
71                       The translation factor elongation factor P, which alleviates pausing at polypro